No Data
No Data
No Data
No Data
No Data
Agios to Webcast Conference Call of First Quarter 2024 Financial Results on May 2, 2024
CAMBRIDGE, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced the company will
GlobeNewswireApr 18 07:00 ET
We're Hopeful That Agios Pharmaceuticals (NASDAQ:AGIO) Will Use Its Cash Wisely
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com made losses for many years after listing, if you had bought and held the shares
Simply Wall StApr 14 08:00 ET
Director Jacqualyn Fouse Sells Shares of Agios Pharmaceuticals Inc (AGIO)
Yahoo FinanceApr 10 19:01 ET
Express News | Cantor Fitzgerald Reiterates Overweight on Agios Pharmaceuticals
Moomoo 24/7Apr 9 08:27 ET
Agios Publishes 2024 Environmental, Social and Governance (ESG) Report
– Report Highlights Company's Focus on Red Blood Cell Health; Diversity, Equity & Inclusion; and Strong Corporate Governance – – Aligns with the Sustainability Accounting Standards Board (SASB) Standards for the
GlobeNewswireApr 9 07:00 ET
We Think Agios Pharmaceuticals (NASDAQ:AGIO) Can Afford To Drive Business Growth
Yahoo FinanceMar 30 09:45 ET
No Data
No Data
MikeyMikeMike : Most all small cap pharma stock has issues with revenue. It's the cost of research and development that smaller companies have to sustain that causes this.